首页 | 本学科首页   官方微博 | 高级检索  
     

吡罗昔康胃肠道安全性数据回顾
引用本文:张亚同,傅得兴,纪立伟,刘治军,孙春华. 吡罗昔康胃肠道安全性数据回顾[J]. 中国药物警戒, 2008, 5(3): 166-170
作者姓名:张亚同  傅得兴  纪立伟  刘治军  孙春华
作者单位:卫生部北京医院药学部,北京,100730
摘    要:
非选择性非甾体抗炎药吡罗昔康的胃肠道不良反应一直受到关注。通过检索PUBMED数据库,结合手工筛选和PuBMED自带的相似文献检索,以及检索Cochrane,查找有关吡罗昔康不良反应和安全性内容的个案和综述文献,并结合最近的相关新闻报道进行总结分析,结果表明吡罗昔康属于胃肠道安全性较差的非甾体抗炎药物。

关 键 词:吡罗昔康  胃肠道安全性  非甾体抗炎药
文章编号:1672-8629(2008)03-0166-05
修稿时间:2008-01-01

The Review of the Gastrointestinal Safety of Piroxicam
ZHANG Ya-tong,FU De-xing,JI Li-wei,LIU Zhi-jun,SUN Chun-hua. The Review of the Gastrointestinal Safety of Piroxicam[J]. Chinese JOurnal of Pharmacovigilance, 2008, 5(3): 166-170
Authors:ZHANG Ya-tong  FU De-xing  JI Li-wei  LIU Zhi-jun  SUN Chun-hua
Affiliation:(Pharmaceutical Department, Beijing Hospital of MiniStry of Health Beijing 100730,China)
Abstract:
The gastrointestinal adverse reaction of piroxicam which is non-selective non-steroidal anti-inflammatory drug has been of great concern. In this paper, we search for gastrointestinal safety data associated with piroxicam in PUBMED database and Cochrane database and therefore give one summary analysis. The result shows that the gastrointestinal safety of piroxicam is relatively poor Compared with other non-steroidal anti-inflammatory drugs.
Keywords:piroxicam  gastrointestinal safety  non-steroidal anti-inflammatory drug
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号